Sugi Predict

Sugi Predict / Compounds / SCHEMBL28488116

SCHEMBL28488116

SCHEMBL28488116

NC(=O)N(c1ccccc1)c1nc2ccccc2s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.54
▸ NPC1 O15118 6/20 0.54
▸ RAB9A P51151 6/20 0.54
▸ LMNA P02545 3/20 0.54
▸ TP53 P04637 1/20 0.54
▸ CASP3 P42574 1/20 0.54
▸ SENP8 Q96LD8 1/20 0.54
▸ SENP7 Q9BQF6 1/20 0.54
▸ SENP6 Q9GZR1 1/20 0.54
▸ TSHR P16473 2/20 0.50
▸ ALOX15 P16050 2/20 0.50
▸ ALOX5 P09917 1/20 0.48
▸ ALDH1A1 P00352 5/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ NPSR1 Q6W5P4 3/20 0.47
▸ HPGD P15428 5/20 0.46
▸ MAPT P10636 2/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ GPR55 Q9Y2T6 1/20 0.46
▸ GAA P10253 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28640787 0.98 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL27907317 0.89 LMNA (0.46) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL8076003 0.88 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL5023451 0.84 SMN1; SMN2 (0.68) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL11727782 0.83 TSHR (0.49) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL9065692 0.78 ALOX15 (0.73) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL3791438 0.78 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL12474111 0.77 LMNA (0.58) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL21753481 0.76 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL27802492 0.76 RAB9A (0.57) SMN1; SMN2NPC1RAB9ALMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112028854-B Benzothiazole phenylurea compounds and preparation and sterilization application thereof 青岛农业大学 2022-04-08 — — CN claimed
CN-112028854-A Benzothiazole phenylurea compounds and preparation and sterilization application thereof 青岛农业大学 2020-12-04 — — CN claimed
CN-107427501-B Methods of treating cancer by combination use 第一三共株式会社 2023-12-01 — — CN disclosed
CN-115515582-A Combination therapy for acute myeloid leukemia 细胞基因公司 2022-12-23 — — CN disclosed
CN-115175937-A Combination of anti-TIM-3 antibody MBG453 and anti-TGF-beta antibody NIS793 with or without decitabine or anti-PD-1 antibody, gabapentin, for the treatment of myelofibrosis and myelodysplastic syndrome 诺华股份有限公司 2022-10-11 — — CN disclosed
CN-114980902-A Combination comprising a TIM-3 inhibitor and a hypomethylated drug for the treatment of myelodysplastic syndrome or chronic myelomonocytic leukemia 诺华股份有限公司 2022-08-30 — — CN disclosed
CN-114786679-A Combination therapy with Vernetork and TIM-3 inhibitors 诺华股份有限公司 2022-07-22 — — CN disclosed
CN-114786680-A TIM-3 inhibitors and uses thereof 诺华股份有限公司 2022-07-22 — — CN disclosed
CN-112028854-B Benzothiazole phenylurea compounds and preparation and sterilization application thereof 青岛农业大学 2022-04-08 — — CN disclosed
CN-112028854-B Benzothiazole phenylurea compounds and preparation and sterilization application thereof 青岛农业大学 2022-04-08 — — CN disclosed
CN-112028854-B Benzothiazole phenylurea compounds and preparation and sterilization application thereof 青岛农业大学 2022-04-08 — — CN disclosed
CN-112028854-A Benzothiazole phenylurea compounds and preparation and sterilization application thereof 青岛农业大学 2020-12-04 — — CN disclosed
CN-112028854-A Benzothiazole phenylurea compounds and preparation and sterilization application thereof 青岛农业大学 2020-12-04 — — CN disclosed
CN-112028854-A Benzothiazole phenylurea compounds and preparation and sterilization application thereof 青岛农业大学 2020-12-04 — — CN disclosed